These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22222426)

  • 21. OCT analysis in patients with very late stent thrombosis.
    Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very late stent thrombosis 5 years after implantation of a sirolimus-eluting stent observed by angioscopy and optical coherence tomography.
    Ishihara T; Awata M; Fujita M; Watanabe T; Iida O; Ishida Y; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2013 May; 6(5):e28-30. PubMed ID: 23702022
    [No Abstract]   [Full Text] [Related]  

  • 24. Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction.
    Rigattieri S; Patrizi R; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Palamara A; Loschiavo P
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):771-4. PubMed ID: 17001240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very late stent thrombosis approximately 7 years after deployment and one-week cessation of dual antiplatelet therapy.
    Taylor-Sutton JE; Kim MC
    J Invasive Cardiol; 2011 Dec; 23(12):E273-6. PubMed ID: 22147407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late coronary thrombosis secondary to a sirolimus-eluting stent.
    Walpoth BH; Hess OM
    Circulation; 2004 Sep; 110(11):e309; author reply e309. PubMed ID: 15364828
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
    Am Heart J; 2009 Oct; 158(4):e43-50. PubMed ID: 19781402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation.
    Kuramitsu S; Iwabuchi M; Haraguchi T; Domei T; Nagae A; Hyodo M; Yamaji K; Soga Y; Arita T; Shirai S; Kondo K; Ando K; Sakai K; Goya M; Takabatake Y; Sonoda S; Yokoi H; Toyota F; Nosaka H; Nobuyoshi M
    Circ Cardiovasc Interv; 2012 Oct; 5(5):663-71. PubMed ID: 23011266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete stent apposition and very late stent thrombosis after everolimus eluting stent implantation and dual antiplatelet therapy interruption. A case of OCT guided therapy.
    Gatto P; Dumonteil N; Boudou N; Van Rothem J; Lhermusier T; Bartorelli A; Carrié D
    Int J Cardiol; 2015 Feb; 180():52-4. PubMed ID: 25438210
    [No Abstract]   [Full Text] [Related]  

  • 31. Very late thrombosis after drug-eluting stents.
    Feres F; Costa JR; Abizaid A
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):83-8. PubMed ID: 16763989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial infarction with acute thrombosis of multiple major coronary arteries: a clinical and angiographic observation in four patients.
    Garbo R; Steffenino G; Dellavalle A; Russo P; Meinardi F
    Ital Heart J; 2000 Dec; 1(12):824-31. PubMed ID: 11152413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kounis syndrome: Identifying the trigger.
    Lorca R; Velasco E; Madera J; Fidalgo A; Alonso-Arias R; Del Valle R; Rozado J; Morís C
    Int J Cardiol; 2016 Apr; 209():179-80. PubMed ID: 26896617
    [No Abstract]   [Full Text] [Related]  

  • 35. Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation.
    Ino Y; Toyoda Y; Tanaka A; Ishii S; Kusuyama Y; Kubo T; Takarada S; Kitabata H; Tanimoto T; Hirata K; Mizukoshi M; Imanishi T; Akasaka T
    Am Heart J; 2010 Oct; 160(4):775.e1-9. PubMed ID: 20934574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute myocardial infarction due to late stent thrombosis seventeen months after stent implantation: a case report].
    Umemura S; Tsuka Y; Nakamura S; Tsuka M; Kitamura T; Yoshida S; Sugiura T; Baden M; Iwasaka T
    J Cardiol; 2005 May; 45(5):205-11. PubMed ID: 15929388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of and safety concerns associated with drug-eluting coronary stents.
    Garg S; Serruys P
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):449-70. PubMed ID: 20222822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting stent thrombosis after 2029 days of placement: longest ever reported interval between drug-eluting stent placement and very late thrombosis.
    Akhtar M; Waked A; Bhat H; Khalid M; Teli S; Saiful FB; Lafferty J; Bhat T
    Future Cardiol; 2011 Nov; 7(6):745-8. PubMed ID: 22050060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myocardial infarction and Kounis syndrome.
    Patanè S; Marte F; Di Bella G; Chiofalo S; Currò A; Coglitore S
    Int J Cardiol; 2009 May; 134(2):e45-6. PubMed ID: 18378025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction.
    Villa A; Arnold R; Sánchez PL; Gimeno F; Ramos B; Cantero T; Fernández ME; Sanz R; Gutiérrez O; Mota P; García-Frade J; San Román JA; Fernández-Avilés F;
    Am J Cardiol; 2009 Jun; 103(12):1651-6. PubMed ID: 19539071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.